Q1 2023 VolitionRX Ltd Earnings Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's first quarter of 2023 earnings conference call. (Operator Instructions) This conference is being recorded today May 11, 2023.
I'd now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations.
Thank you, and welcome everyone to today's earnings conference call for VolitionRx Limited. This call will cover Volition's financial and operating results for the first quarter of 2023, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session.
Also, on our call today are Mr. Cameron Reynolds, President and Group Chief Executive Officer; Dr. Tom Butera, Chief Executive Officer of our Volition Veterinary subsidiary; and Mr. Terig Hughes, Group Chief Financial Officer.
Before we begin, I'd like to remind everyone that some of the information discussed on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |